Dermatologists' Knowledge, Attitude, and Practice Pattern Toward Low-Dose Oral Minoxidil in Hair Loss in Saudi Arabia

A cross-sectional study involving 84 dermatologists in Saudi Arabia evaluated their knowledge and attitudes towards Low-Dose Oral Minoxidil (LDOM) for hair loss treatment. The study found that 99% of participants recognized patterned hair loss as an indication for LDOM, with 67% selecting 2.5 mg as the most commonly used dose. Side effects like hypertrichosis and hypotension were recognized by 92% and 82% of participants, respectively. While 98% were aware that LDOM could be combined with other treatments, only 48% prescribed it, mainly due to its unavailability in local pharmacies. The study concluded that despite recognizing LDOM as a safe and effective treatment, there's a knowledge gap among these dermatologists about its side effects and safety. The authors recommend increasing awareness and understanding of LDOM through educational initiatives and further studies.